These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26942001)

  • 1. Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation.
    Najafi M; Kordi-Tamandani DM; Arish M
    J Ophthalmol; 2016; 2016():5431021. PubMed ID: 26942001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of LATS1 and LATS2 promoter methylation in OSCC development.
    Ladiz MA; Najafi M; Kordi-Tamandani DM
    J Cell Commun Signal; 2017 Mar; 11(1):49-55. PubMed ID: 27761802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
    Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
    Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.
    Malik SA; Khan MS; Dar M; Hussain MU; Shah MA; Shafi SM; Mudassar S
    Pathol Oncol Res; 2018 Apr; 24(2):207-214. PubMed ID: 28434174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to investigation of the pathogenesis of pterygium based on assessment of promoter hyper-methylation and expression profile of CTLA4 gene: A credible report of CTLA4 gene expression in human eye tissue.
    Ebrahimi ME; Kordi-Tamandani DM; Arish M
    Gene; 2016 Jun; 583(2):130-133. PubMed ID: 26899867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of the large tumor suppressor genes in Japanese lung cancer.
    Sasaki H; Hikosaka Y; Kawano O; Yano M; Fujii Y
    Oncol Lett; 2010 Mar; 1(2):303-307. PubMed ID: 22966299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer.
    Luo SY; Kwok HH; Yang PC; Ip MS; Minna JD; Lam DC
    Transl Lung Cancer Res; 2020 Apr; 9(2):294-305. PubMed ID: 32420069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.
    Li ZG; Fu XM; Chai CY; Sun FF; Xiao FF; Huang YX; Yao K; Chen JP; Hou Y
    Chin Med J (Engl); 2020 Aug; 133(16):1943-1951. PubMed ID: 32826458
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Li L; Dong L; Wang Y; Zhang X; Yan J
    Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Promoter Hypermethylation and Expression Profile of P14ARF and MDM2 Genes in Patients With Pterygium.
    Arish M; Kordi-Tamandani DM; Sangterash MH; Poyandeh R
    Eye Contact Lens; 2016 Jan; 42(1):e4-7. PubMed ID: 26020483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of LATS family proteins in ovarian tumors and its significance.
    Xu B; Sun D; Wang Z; Weng H; Wu D; Zhang X; Zhou Y; Hu W
    Hum Pathol; 2015 Jun; 46(6):858-67. PubMed ID: 25841306
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Matsui S; Kagara N; Mishima C; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Oncol Lett; 2018 Feb; 15(2):2595-2603. PubMed ID: 29434979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological Significance of Large Tumor Suppressor (
    Son MW; Song GJ; Jang SH; Hong SA; Oh MH; Lee JH; Baek MJ; Lee MS
    J Gastric Cancer; 2017 Dec; 17(4):363-373. PubMed ID: 29302376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
    Yue ZW; Liu JZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative expression of zebrafish lats1 and lats2 and their implication in gastrulation movements.
    Chen CH; Sun YH; Pei DS; Zhu ZY
    Dev Dyn; 2009 Nov; 238(11):2850-9. PubMed ID: 19842174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Members Reveals Specific Alteration Pattern in Diffuse Gliomas.
    Levallet G; Creveuil C; Bekaert L; Péres E; Planchard G; Lecot-Cotigny S; Guillamo JS; Emery E; Zalcman G; Lechapt-Zalcman E
    J Mol Diagn; 2019 Jul; 21(4):695-704. PubMed ID: 31055025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
    Reddy VR; Annamalai T; Narayanan V; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of LATS mRNA in mantle cell lymphoma and its clinical significance].
    Yu Z; Yi S; Zhang Y; Li Z; Qiu L
    Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(40):3285-8. PubMed ID: 26815349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state.
    Furth N; Pateras IS; Rotkopf R; Vlachou V; Rivkin I; Schmitt I; Bakaev D; Gershoni A; Ainbinder E; Leshkowitz D; Johnson RL; Gorgoulis VG; Oren M; Aylon Y
    Life Sci Alliance; 2018 Oct; 1(5):e201800171. PubMed ID: 30456386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.